Completed NA INTERVENTIONAL 2-arm NCT01487759

Prebiotic Effect on Metabolites in Crohn's Disease

Metabolite Profiling of the Impact of Oligofructose Enriched Inulin in Crohn's Disease Patients

Sponsor: KU Leuven

Interventions Maltodextrin Oligofructose enriched inulin

Updated 6 times since 2017 Last updated: Dec 9, 2011 Started: Mar 31, 2008 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01487759, this NA trial focuses on Crohn Disease and remains completed. Sponsored by KU Leuven, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2018 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Aug 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

KU Leuven

Data source: KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leuven, Belgium